Variant report
Variant | nsv981206 |
---|---|
Chromosome Location | chr6:167114881-167115499 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188604316 | chr6:167114882-167114883 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs535481377 | chr6:167114905-167114906 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs16899309 | chr6:167114930-167114931 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs193167391 | chr6:167114931-167114932 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs375732454 | chr6:167114951-167114952 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140692257 | chr6:167114988-167114989 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs557853546 | chr6:167115080-167115081 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs576938585 | chr6:167115082-167115083 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs541252935 | chr6:167115094-167115095 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs79682448 | chr6:167115129-167115130 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574722602 | chr6:167115142-167115143 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs542144628 | chr6:167115198-167115199 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185292197 | chr6:167115206-167115207 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs530533613 | chr6:167115234-167115235 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs113893559 | chr6:167115258-167115259 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545884935 | chr6:167115268-167115269 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564242734 | chr6:167115290-167115291 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs57100456 | chr6:167115306-167115307 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs547221250 | chr6:167115310-167115311 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568566694 | chr6:167115349-167115350 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529503497 | chr6:167115364-167115365 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs550878135 | chr6:167115382-167115383 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs568884540 | chr6:167115385-167115386 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs111444081 | chr6:167115407-167115408 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs190189907 | chr6:167115432-167115433 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs66759203 | chr6:167115448-167115449 | Weak transcription Enhancers Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs534511764 | chr6:167115459-167115460 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Epilepsy | 22083797 | CNVD |
Myelofibrosis | 22110671 | CNVD |
chordoma | 19801981 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Autism | 17483303 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Ependymoma | 20639864 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:167102200-167116000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr6:167102200-167116600 | Weak transcription | Brain Anterior Caudate | brain |
3 | chr6:167102200-167117600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr6:167109200-167117000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr6:167112800-167115200 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
6 | chr6:167112800-167116600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr6:167113600-167115200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
8 | chr6:167113600-167115200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr6:167114000-167115000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
10 | chr6:167115000-167115200 | Enhancers | H1 Cell Line | embryonic stem cell |
11 | chr6:167115000-167120800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
12 | chr6:167115200-167115800 | Weak transcription | H1 Cell Line | embryonic stem cell |
13 | chr6:167115200-167116000 | Strong transcription | Primary neutrophils fromperipheralblood | blood |
14 | chr6:167115200-167120400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
15 | chr6:167115400-167118400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |